Elevated ALT (HR = 1.008, 95% CI: 1.001–1.015, P = 0.022) and tumor diameter (HR = 1.263, 95% CI: 1.052–1.517, P = 0.012) were identified as independent adverse prognostic factors, suggesting that larger tumor burden is associated with higher recurrence risk. The gene discussed is GPT; the disease is neoplasm.